Characteristics of metabolically obese, normal-weight women differ by menopause status: The Fourth Korea National Health and Nutrition Examination Survey

Menopause

Volumn 20, Issue 1, 2013, Pages 85-93

  Choi, Jin Young ^a   Ha, Hee Sung ^a   Kwon, Hyuk Sang ^b   Lee, Seung Hwan ^b   Cho, Hyun Hee ^a   Yim, Hyeon Woo ^a   Lee, Won Chul ^a   Park, Yong Moon ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Insulin resistance; Menopause; Metabolic syndrome; Metabolically obese, normal weight

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; FERRITIN; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLICALLY OBESE NORMAL WEIGHT; NUTRITIONAL ASSESSMENT; OBESITY; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; RURAL AREA; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ALANINE TRANSAMINASE; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CHOLESTEROL, HDL; EXERCISE; FEMALE; HEALTH SURVEYS; HUMANS; INSULIN RESISTANCE; LEUKOCYTE COUNT; MENOPAUSE; METABOLIC SYNDROME X; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PHENOTYPE; POSTMENOPAUSE; PREMENOPAUSE; REPUBLIC OF KOREA; RURAL POPULATION; YOUNG ADULT;

EID: 84872092164     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31825d26b6     Document Type: Article

References (53)

1. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
2. Pérez Pérez A, Ybarra Muñoz J, Blay Cortés V, de Pablos Velasco P. Obesity and cardiovascular disease. Public Health Nutr 2007;10: 1156-1163.
3. Naser KA, Gruber A, Thomson GA. The emerging pandemic of obesity and diabetes: are we doing enough to prevent a disaster? Int J Clin Pract 2006;60:1093-1097.
4. Ruderman NB, Schneider SH, Berchtold P. The Bmetabolically-obese,[ normal-weight individual. Am J Clin Nutr 1981;34:1617-1621.
5. Wildman RP, Muntner P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168:1617-1624.
6. St-Onge MP, Janssen I, Heymsfield SB. Metabolic syndrome in normalweight Americans: new definition of the metabolically obese, normalweight individual. Diabetes Care 2004;27:2222-2228.
7. Conus F, Allison D, Rabasa-Lhoret R, et al. Metabolic and behavioral characteristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004;89:5013-5020.
8. Dvorak RV, DeNino WF, Ades PA, Poehlman ET. Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes 1999;48:2210-2214.
9. Hyun YJ, Koh SJ, Chae JS, et al. Atherogenecity of LDL and unfavorable adipokine profile in metabolically obese, normal-weight woman. Obesity (Silver Spring) 2008;16:784-789.
10. Meigs JB, Wilson PW, Fox CS, et al. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91:2906-2912.
11. WHO Expert Consultation Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
12. Park HS, Oh SW, Cho SI, Choi WH, Kim YS. The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol 2004;33:328-336.
13. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411.
14. Lloyd-Jones D, Adams R, Carnethon M, et al. Heart disease and stroke statisticsV2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119:480-486.
15. Janssen I, Powell LH, Crawford S, Lasley B, Sutton-Tyrrell K. Menopause and the metabolic syndrome: the Study of Women's Health Across the Nation. Arch Intern Med 2008;168:1568-1575.
16. Franklin RM, Ploutz-Snyder L, Kanaley JA. Longitudinal changes in abdominal fat distribution with menopause. Metabolism 2009;58:311-315.
17. Lejsková M, Aluxík S, Suchánek M, Zecová S, Pitha J. Menopause: clustering of metabolic syndrome components and population changes in insulin resistance. Climacteric 2011;14:83-91.
18. Hu JF, Zhao XH, Chen JS, Fitzpatrick J, Parpia B, Campbell TC. Bone density and lifestyle characteristics in premenopausal and postmenopausal Chinese women. Osteoporos Int 1994;4:288-297.
19. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre-and postmenopausal women (United Kingdom). Cancer Causes Control 2001;12:47-59.
20. Kruk J. Association of lifestyle and other risk factors with breast cancer according to menopausal status: a case-control study in the Region of Western Pomerania (Poland). Asian Pac J Cancer Prev 2007;8:513-524.
21. CLSI. Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline. Wayne, PA: National Committee for Clinical Laboratory Standards, 1995.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and A-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
23. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
24. Conus F, Rabasa-Lhoret R, Péronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007; 32:4-12.
25. Lee SH, Ha HS, Park YJ, et al. Identifying metabolically obese but normal-weight (MONW) individuals in a nondiabetic Korean population: the Chungju Metabolic disease Cohort (CMC) study. Clin Endocrinol (Oxf ) 2011;75:475-481.
26. Onishi Y, Honda M, Ogihara T, et al. Ethanol feeding induces insulin resistance with enhanced PI 3-kinase activation. Biochem Biophys Res Commun 2003;303:788-794.
27. Lichtenstein AH, Schwab US. Relationship of dietary fat to glucose metabolism. Atherosclerosis 2000;150:227-243.
28. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001;24:925-932.
29. Toth MJ, Sites CK, Eltabbakh GH, Poehlman ET. Effect of menopausal status on insulin-stimulated glucose disposal: comparison of middle-aged premenopausal and early postmenopausal women. Diabetes Care 2000; 23:801-806.
30. Lindheim SR, Buchanan TA, Duffy DM, et al. Comparison of estimates of insulin sensitivity in pre-and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig 1994;1:150-154.
31. Godsland IF. Oestrogens and insulin secretion. Diabetologia 2005;48: 2213-2220.
32. Lim S, Shin H, Song JH, et al. Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998-2007. Diabetes Care 2011;34:1323-1328.
33. National Health and Nutrition Examination Survey Report 2008. Seoul, Korea: Korean Ministry of Health and Welfare, 2009.
34. United Nations. World population ageing 1950-2050. 2001. Available at: http://www.un.org/esa/population/publications/worldageing19502050/. Accessed April 10, 2012.
35. Stein AD, Thompson AM, Waters A. Childhood growth and chronic disease: evidence from countries undergoing the nutrition transition. Matern Child Nutr 2005;1:177-184.
36. Lopez-Jaramillo P. Cardiometabolic disease in Latin America: the role of fetal programming in response to maternal malnutrition. Rev Esp Cardiol 2009;62:670-676.
37. Labor Market Survey 2008. Seoul, Korea: Korea National Statistical Office, 2008.
38. Prevalence and trends data. Behavioral risk factor surveillance system. 2007. Available at: http://apps.nccd.cdc.gov/brfss/sex.asp?cat=PA&yr= 2007&qkey=4418&state=US. Accessed April 10, 2012.
39. Angelico F, Del Ben M, Conti R, et al. Insulin resistance, the metabolic syndrome, and nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2005;90:1578-1582.
40. Suzuki A, Abdelmalek MF. Nonalcoholic fatty liver disease in women. Womens Health (Lond, Engl) 2009;5:191-203.
41. Riesco E, Roussel M, Lemoine S, Garnier S, Sanguignol F, Mauriege P. What is the influence of menopausal status on metabolic profile, eating behaviors, and perceived health of obese women after weight reduction? Appl Physiol Nutr Metab 2008;33:957-965.
42. Wajchenberg BL, Malerbi DA, Rocha MS, Lerario AC, Santomauro AT. Syndrome X: a syndrome of insulin resistance. Epidemiological and clinical evidence. Diabetes Metab Rev 1994;10:19-29.
43. Stern JS, Batchelor BR, Hollander N, Cohn CK, Hirsch J. Adipose-cell size and immunoreactive insulin levels in obese and normal-weight adults. Lancet 1972;2:948-951.
44. Helmerhorst HJ, Wijndaele K, Brage S, Wareham NJ, Ekelund U. Objectively measured sedentary time may predict insulin resistance independent of moderate-and vigorous-intensity physical activity. Diabetes 2009;58:1776-1779.
45. Hasbum B, Real JT, Sanchez C, et al. Effects of a controlled program of moderate physical exercise on insulin sensitivity in nonobese, nondiabetic subjects. Clin J Sport Med 2006;16:46-50.
46. Ilanne Parikka P, Laaksonen DE, Eriksson JG, et al. Leisure-time physical activity and the metabolic syndrome in the Finnish Diabetes Prevention Study. Diabetes Care 2010;33:1610-1617.
47. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. Curr Diab Rep 2005;5:70-75.
48. Lim S, Jang HC, Lee HK, Kimm KC, Park C, Cho NH. A rural-urban comparison of the characteristics of the metabolic syndrome by gender in Korea: the Korean Health and Genome Study (KHGS). J Endocrinol Invest 2006;29:313-319.
49. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: an urbanrural comparison. Diabetes Care 2001;24:275-279.
50. Browning LM, Hsieh SD, Ashwell M. A systematic review of waistto-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value. Nutr Res Rev 2010;23:247-269.
51. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
52. Bonora E, Targher G, Alberiche M, et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
53. Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism 2010;59: 299-304.